← Back to Search

Behavioural Intervention

Bright light therapy glasses for Obstructive Sleep Apnea

N/A
Waitlist Available
Led By Isabella Soreca, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to week 12
Awards & highlights

Study Summary

This trial will study whether Bright Light Therapy can help improve the residual daytime symptoms in people with Obstructive Sleep Apnea who are using Continuous Positive Airway Pressure.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Epworth Sleepiness Scale
Functional Outcomes of Sleep Questionnaire (FOSQ-10)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Retimer bright light therapy glassesExperimental Treatment1 Intervention
active bright light therapy in the green/blue spectrum range
Group II: sham-Retimer bright light therapy glassesPlacebo Group1 Intervention
bright light therapy with light in the red spectrum (not active)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bright light therapy glasses
2020
N/A
~20

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,419 Total Patients Enrolled
Isabella Soreca, MDPrincipal InvestigatorVA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025